Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Levothyroxine Sodium Tablets

Approval Number

国药准字HJ20160236

CompanyBERLIN-CHEMIE AG

Registration Date

December 1, 2020

Previous Approval Numbers

H20160236

Drug Information

Generic Name

左甲状腺素钠片

Trade Name

雷替斯

Brand Name

雷替斯

Dosage Form

片剂

Strength

100μg

Drug Type

化学药品

Registration Date

December 1, 2020

Expiry Date

November 30, 2025

Company Information

Applicant Company

Company NameBERLIN-CHEMIE AG

Company Address

Glienicker Weg 125，D-12489，Berlin ,Germany

Manufacturing Company

Company NameBERLIN-CHEMIE AG

Company Address

Tempelhofer Weg 83, D-12347 Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy